Please reload

Recent Posts

Patient survives Brain Eating Amoeba

September 12, 2016

Please reload

Featured Posts

Profounda OutLicenses right to development product

December 6, 2013



Profounda completes ex-US licensing outlicensing rights for a product in development in exchange for upfront milestone and downstream royalties.exceeding $1 Million.

Please reload

Follow Us
Please reload

Search By Tags
Please reload

  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

© Profounda Pharmaceuticals